• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Defensive·KO
Held by 4 Gurus
Share

The Coca-Cola Company Stocks

$ 87.05Last Updated 07.08.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 374.54B

$ 87.05
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Greg Abel

Portfolio Weight (%)

11.6%

Change

+1.36%

Fund

Berkshire Hathaway

Steven Cohen

Portfolio Weight (%)

0.3%

Change

+0.12%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.2%

Change

+0.09%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Greg AbelBerkshire Hathaway11.6%+1.36%
Steven CohenPoint72 Asset Management, L.P.0.3%+0.12%
Kenneth GriffinCITADEL ADVISORS LLC0.2%+0.09%
Show more

Latest news

29.07.2026 15:27

Morning in New York: The Market Awaits a Turning Point

22.06.2026 15:15

Morning in New York: Geopolitics Favors Buyers

29.04.2026 15:46

Morning in New York: Fed rate hike and megacaps

28.04.2026 21:16

Coca-Cola posted its best revenue growth since 2024 thanks to mini-packs

31.03.2026 21:08

'Use cachet in case of collapse': Buffett on correction, nuclear threat and Apple mistake

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

The Coca-Cola Company is a global beverage giant that produces and distributes a wide array of nonalcoholic drinks worldwide. Its extensive product portfolio includes carbonated soft drinks, various flavored waters, sports drinks, coffee, and tea, alongside juices, enriched dairy products, and plant-based alternatives. The company also supplies beverage concentrates and syrups, such as fountain syrups for food service establishments and convenience stores. With a vast collection of well-known brands like Coca-Cola, Fanta, Sprite, Simply, and Dasani, among many others, it reaches consumers through an intricate network of independent bottlers, distributors, wholesalers, and retailers, as well as its own operational facilities. Established in 1886, The Coca-Cola Company is based in Atlanta, Georgia.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of KO is 101 and suggests 15.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.08.2026 17:47

Analysts have predicted renewed growth in the European defense sector. Which stocks will benefit?

11.08.2026 17:25

Mid-cap biotech stocks soared on the back of successful trials of a hot flash treatment

11.08.2026 16:55

The price of gold rose above $4,400. Citadel identified a rare combination of factors driving the rise

11.08.2026 16:30

Biotech firm Sionna unexpectedly failed its drug trials and lost 90% of its value in a single day

11.08.2026 16:08

Brent crude has approached $90. An analyst warned of the risk of a price spike as early as next week

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026